TAXONOMY PATHWAYS

taXonomy Pathways combines closed claims with labs, EHR, including clinician notes, to deliver a comprehensive view of inflammatory skin disease. The psoriasis cohort provides:

• 
  Closed claims: 3.1 M patients
• 
  Pharmacy claims: 2.8 M patients (≈ 90 %)
• 
  EHR data: 1.4 M patients (≈ 45 %) with PASI scores and body‑surface area
• 
  Lab data: 2.4 M patients (≈ 76 %) with inflammatory markers and lipid panels

Fill out the form to schedule a meeting and explore our psoriasis dataset.